piracetam has been researched along with Creutzfeldt-Jakob Syndrome in 4 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Creutzfeldt-Jakob Syndrome: A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belcastro, V | 1 |
| Mattucci, E | 1 |
| Rossi, A | 1 |
| Calabresi, P | 1 |
| Tambasco, N | 1 |
| Imperiale, D | 1 |
| Bortolotto, S | 1 |
| Cucatto, A | 1 |
| Schiffer, P | 1 |
| Cassano, D | 1 |
| Buffa, C | 1 |
| Nalbandian, RM | 1 |
| Murayama, M | 1 |
| Henry, RL | 1 |
| Rossini, PM | 1 |
| Caltagirone, C | 1 |
| David, P | 1 |
| Macchi, G | 1 |
1 trial available for piracetam and Creutzfeldt-Jakob Syndrome
| Article | Year |
|---|---|
Jakob-Creutzfeldt disease: analysis of EEG and evoked potentials under basal conditions and neuroactive drugs.
Topics: Aged; Cerebral Cortex; Clinical Trials as Topic; Creutzfeldt-Jakob Syndrome; Diazepam; Electroenceph | 1979 |
3 other studies available for piracetam and Creutzfeldt-Jakob Syndrome
| Article | Year |
|---|---|
Vomiting due to intravenous levetiracetam in a case of Creutzfeldt-Jakob disease.
Topics: Anticonvulsants; Creutzfeldt-Jakob Syndrome; Female; Humans; Injections, Intravenous; Levetiracetam; | 2010 |
Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease.
Topics: Adult; Anticonvulsants; Creutzfeldt-Jakob Syndrome; Humans; Levetiracetam; Male; Myoclonus; Piraceta | 2003 |
Restoration of phagocytosis and oxidative metabolism by Piracetam in failing human neutrophils: a qualitative assessment.
Topics: Adolescent; Adult; Aged; Child; Creutzfeldt-Jakob Syndrome; Diabetic Ketoacidosis; Female; Fetal Blo | 1983 |